Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81–95 peptide show effective antitumor activity against ovarian carcinoma

Xiaoyan Zhang(Fujian Medical University), Congjian Xu(Shanghai Medical College of Fudan University), Hong Sun(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yufang Zheng(Fudan University), Jun Chen(Liaoning Technical University), Shanshan Hong(Obstetrics and Gynecology Hospital of Fudan University), Yu Kang(Obstetrics and Gynecology Hospital of Fudan University)
International Journal of Pharmaceutics
June 25, 2013
Cited by 38


Related Papers